Final Surprise Billing Rule Gets Mixed Reactions

By Amy Lotven / August 22, 2022 at 10:15 AM
Stakeholders who wanted the administration to stick to the proposed rule on the surprise billing law’s independent dispute resolution (IDR) process have mixed reviews of the final rule out Friday (Aug. 19). Consumer and patient advocates applaud the Biden administration for maintaining the spirit of the proposed rule by continuing to make clear that the qualifying payment amount (QPA), or median in–network rate, is the key component in payment determinations, even though the administration no longer demands arbiters select an...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.